Option chain shows key data for CSPC Pharmaceutical Group's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for CSPC Pharmaceutical Group.

CSPC Pharmaceutical Group (OTC:CSPCY) Stock, Option Chain

CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C and antibiotics.

Penny Stocks

CSPCY

Key Takeaways:


	CSPC Pharmaceutical beat market forecasts with double-digit growth in first-quarter revenues and profits, driven by rising sales of drugs to treat strokes and dementia 
	The company has dozens of candidate drugs in the pipeline, under the direction of a reconfigured management team 


By Ken Lo 

CSPC Pharma Weighs Up Diet Drug For Bigger Bottom Line

Key Takeaways:


	BenQ Hospital has filed to list in Hong Kong, reporting its revenue rose 15% last year to 2.69 billion yuan 
	China’s largest private hospital operator will use its IPO funds to expand and upgrade its existing facilities


By Lau Chi Hang

BenQ Hospital Files For IPO As Business Looks Stable, But With Few Growth Spots

Government

News

Regulations

Media

BNTX

MRNA


	Chinese health authorities approved CSPC Pharmaceuticals Group Ltd&#39;s (OTC: CSPCY) messenger RNA (mRNA) COVID-19 vaccine for emergency use authorization.


China&#39;s First mRNA Vaccine: Drugmaker CSPC Wins China&#39;s Approval For COVID-19 Vaccine

CSPC PHARMS GRP U/ADR by CSPC Pharmaceuticals Group Ltd.

Comments

CSPC Pharmaceutical Group

CSPC Pharmaceutical Group (CSPCY) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell